Menu

Outlook Therapeutics, Inc. OTLK

Full chart Compare
Set alert

Price alert · OTLK

All alert types
0.46 USD 0.00 (+0.28%)

At closeNov 10, 2026, 7:51 PM EST

0.46 0.00 +0.74%

After hours · Nov 10, 7:51 PM ET

0.446 Day range 0.468
0.161 52-week range 2.54
YTD
-70.85%
1 year
-63.44%

Revenue & Expenses

Other Income → Expenses: $3.08MIncome Tax Benefit → Expenses: $1.55MExpenses → Selling, General & Admin: $39.94MExpenses → Research & Development: $27.78MGross Profit → Expenses: $657.21KRevenue → Gross Profit: $657.21KRevenue → Cost of Revenue: $756.33KNet Loss → Expenses: $62.42MOther Income$3.08MIncome Tax Benefit$1.55MGross Profit$657.21KNet Loss$62.42MCost of Revenue$756.33KExpenses$67.72MSelling, General & Admin$39.94MResearch & Development$27.78MRevenue$1.41M

Latest period ending Sep 30, 2025 · select a line to chart its full history

Annual income statement

OTLK annual income statement
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
1.41M0000
1.41M0000
1.36M0000
57.20K0000
67.12M71.70M53.13M63.07M51.73M
27.18M41.76M26.45M42.33M38.96M
39.94M29.94M26.67M20.74M12.77M
-67.06M-71.70M-53.13M-63.07M-51.73M
283.13K3.16M2.53M1.49M936.13K
-1.55M2.80K2.80K2.80K2.00K
-62.42M-75.37M-58.98M-66.05M-53.16M
-62.42M-75.37M-58.98M-66.05M-53.16M
-62.42M-75.37M-58.98M-66.05M-53.16M
-62.42M-75.37M-58.98M-66.05M-53.16M
-1.79-4.06-4.72-6.20-7.00
-1.79-4.06-4.72-6.20-7.00
-1.79-4.06-4.72-6.20-7.00
-63.69M-72.21M-56.45M-64.56M-52.23M
-63.69M-72.21M-56.45M-64.56M-52.23M
34.80M18.55M12.51M10.60M7.63M
34.80M18.55M12.51M10.60M7.63M